HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ashutosh Dash Selected Research

Arthritis (Polyarthritis)

1/2018Barium titanate microparticles as potential carrier platform for lanthanide radionuclides for their use in the treatment of arthritis.
10/2016Hydroxyapatite (HA) microparticles labeled with (32)P - A promising option in the radiation synovectomy for inflamed joints.
6/2014Preparation, evaluation, and first clinical use of 177Lu-labeled hydroxyapatite (HA) particles in the treatment of rheumatoid arthritis: utility of cold kits for convenient dose formulation at hospital radiopharmacy.
12/2012Availability of yttrium-90 from strontium-90: a nuclear medicine perspective.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ashutosh Dash Research Topics

Disease

66Neoplasms (Cancer)
04/2021 - 08/2008
13Breast Neoplasms (Breast Cancer)
04/2021 - 01/2015
13Pain (Aches)
01/2020 - 09/2013
12Neoplasm Metastasis (Metastasis)
01/2020 - 07/2012
9Melanoma (Melanoma, Malignant)
09/2019 - 07/2012
8Prostatic Neoplasms (Prostate Cancer)
01/2020 - 04/2014
8Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2019 - 09/2013
7Hepatocellular Carcinoma (Hepatoma)
04/2024 - 09/2013
6Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2019 - 09/2013
5Infections
01/2020 - 01/2017
4Arthritis (Polyarthritis)
01/2018 - 12/2012
3Liver Neoplasms (Liver Cancer)
07/2020 - 02/2017
3Infertility (Sterility)
03/2019 - 06/2015
3Fibrosarcoma
01/2018 - 01/2016
2Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 11/2016
2B-Cell Lymphoma (Lymphoma, B Cell)
12/2019 - 08/2015
2Carcinoma (Carcinomatosis)
09/2018 - 08/2009
2Rheumatoid Arthritis
06/2014 - 07/2012
2Retinoblastoma (Glioblastoma, Retinal)
02/2014 - 07/2012
1Thrombosis (Thrombus)
04/2024
1Myocardial Infarction
01/2023
1Burkitt Lymphoma (Burkitt's Lymphoma)
07/2021
1Necrosis
04/2020
1Thyroid Neoplasms (Thyroid Cancer)
02/2020

Drug/Important Bio-Agent (IBA)

15RadiopharmaceuticalsIBA
12/2020 - 07/2012
13Peptides (Polypeptides)IBA
01/2020 - 12/2012
11AcidsIBA
10/2020 - 11/2013
101,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
11/2019 - 02/2013
9Radioisotopes (Radionuclides)IBA
01/2020 - 09/2013
6IntegrinsIBA
12/2020 - 01/2015
61,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
10/2019 - 02/2018
5Chelating AgentsIBA
04/2024 - 02/2018
5PorphyrinsIBA
03/2021 - 11/2013
5Monoclonal AntibodiesIBA
10/2020 - 12/2012
5LigandsIBA
01/2020 - 01/2017
51,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid) (DOTMP)IBA
01/2019 - 02/2014
4DNA (Deoxyribonucleic Acid)IBA
03/2021 - 01/2017
4arginyl-glycyl-aspartic acidIBA
12/2020 - 02/2013
4Pentetic Acid (DTPA)FDA LinkGeneric
10/2020 - 01/2016
41- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
03/2020 - 01/2017
4ribosomal protein S30IBA
01/2020 - 01/2017
3Ethiodized Oil (Ethiodol)FDA Link
04/2024 - 02/2017
3Trastuzumab (Herceptin)FDA Link
03/2021 - 01/2017
3N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
12/2019 - 03/2017
3Rituximab (Mabthera)FDA Link
11/2019 - 08/2015
3GE 68IBA
09/2019 - 02/2013
3NGR peptideIBA
07/2019 - 01/2017
3Somatostatin Receptors (Somatostatin Receptor)IBA
12/2017 - 04/2017
3Peptide Receptors (Peptide Receptor)IBA
09/2017 - 03/2015
2N- (2- amino- 3- (para- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N,N',N',N'- pentaacetic acidIBA
10/2020 - 08/2015
2human ERBB2 proteinIBA
10/2020 - 04/2020
2ubiquicidin 31-38IBA
01/2020 - 07/2018
2Intercalating AgentsIBA
01/2020 - 01/2020
2aspartic acid glycine arginineIBA
09/2019 - 06/2015
2cyclic arginine-glycine-aspartic acid peptideIBA
05/2019 - 02/2013
2EndotoxinsIBA
03/2019 - 06/2015
2Etidronic Acid (HEDP)FDA LinkGeneric
10/2018 - 06/2017
2Rhenium-188IBA
10/2018 - 07/2012
2Gallium-68IBA
07/2018 - 09/2016
2NucleosidesIBA
05/2018 - 09/2017
2GemcitabineFDA Link
05/2018 - 09/2017
2Bevacizumab (Avastin)FDA Link
05/2017 - 01/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017 - 01/2016
2Durapatite (Hydroxylapatite)IBA
10/2016 - 06/2014
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
04/2015 - 03/2015
1Biomarkers (Surrogate Marker)IBA
01/2023
1CamptothecinIBA
07/2021
1ProdrugsIBA
04/2021
1Cisplatin (Platino)FDA LinkGeneric
04/2021
11-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2021
1tetra(4-N-methylpyridyl)porphineIBA
03/2021
1protein KIBA
03/2021
1Antigen Receptors (Antigen Receptor)IBA
03/2021
1ThioureaIBA
01/2021
1ThiadiazolesIBA
01/2021
1benzothiazoleIBA
01/2021
1N- (2- amino- 3- (4- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N',N',N'',N''- pentaacetic acidIBA
10/2020
1Immunoconjugates (Immunoconjugate)IBA
04/2020
1Aluminum Oxide (Sapphire)IBA
02/2020
1SolutionsIBA
02/2020
1EstersIBA
01/2020
1Radium-223IBA
01/2020
1Antimicrobial PeptidesIBA
01/2020
1AcridinesIBA
01/2020
1Aminacrine (Aminoacridine)IBA
01/2020
1DisulfidesIBA
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1Glutathione (Reduced Glutathione)IBA
01/2020
1Sulindac (Copal)FDA LinkGeneric
01/2020

Therapy/Procedure

24Therapeutics
04/2024 - 09/2013
7Brachytherapy
07/2015 - 08/2008
6Precision Medicine
04/2021 - 01/2016
6Radioimmunotherapy
12/2019 - 08/2015
4Synovectomy
01/2018 - 09/2013
3Radiotherapy
07/2020 - 07/2012
2Castration
01/2020 - 01/2018
2Microspheres (Microsphere)
01/2018 - 05/2016
2Palliative Care (Palliative Therapy)
01/2017 - 02/2016
1Drug Therapy (Chemotherapy)
04/2021